Results 71 to 80 of about 8,469 (207)

Long-term cardiac (valvulopathy) safety of cabergoline in prolactinoma

open access: yesIndian Journal of Endocrinology and Metabolism, 2017
Background: Clinical relevance of association of cabergoline use for hyperprolactinemia and cardiac valvulopathy remains unclear. Objective: The aim of the study was to determine the prevalence of valvular heart abnormalities in patients taking ...
Shruti Khare   +6 more
doaj   +1 more source

A study on the correlations of PRL levels with anxiety, depression, sleep, and self-efficacy in patients with prolactinoma

open access: yesFrontiers in Endocrinology
PurposeThe purpose of this study was to explore the factors influencing PRL levels in patients with prolactinoma and to investigate the correlations between anxiety, depression, sleep, self-efficacy, and PRL levels.MethodsThis retrospective study ...
Xiaoju Miao   +14 more
doaj   +1 more source

Mean platelet volume in patients with prolactinoma

open access: yesArchives of Endocrinology and Metabolism, 2016
Objective Prolactin is a multifunctional pituitary hormone. The effect of prolactin on platelet activation is not well understood. Prolactinomas are the most common type of pituitary adenomas, and they are medically responsive to dopamine agonists. Mean
Abbas Ali Tam   +4 more
doaj   +1 more source

Massive prolactinoma with galactorrhoea in a prepubertal boy [PDF]

open access: bronze, 1989
R.J.M. Ross   +5 more
openalex   +1 more source

A case of an ectopic prolactinoma

open access: yesGynecological Endocrinology, 2011
A 34-year-old female presented to our clinic with a 1.5 year history of secondary amenorrhea and galactorrhea. Prolactin (PRL) level was found to be 151.89 ng/ml. Pituitary imaging was reported to be normal. An examination of the patient revealed that PRL level was still high so the dose of cabergoline was further increased and subsequently ...
Simsir, Ilgin Yildirim   +7 more
openaire   +3 more sources

Malignant Prolactinoma Discovered by D2 Receptor Imaging [PDF]

open access: bronze, 2000
Patrick Pétrossians   +5 more
openalex   +2 more sources

Prolactinoma Manifesting With Symptomatic Hydrocephalus [PDF]

open access: bronze, 1999
Ofer M. Zikel   +2 more
openalex   +1 more source

Medical treatment of prolactinomas

open access: yesNature Reviews Endocrinology, 2011
Prolactinomas, the most prevalent type of neuroendocrine disease, account for approximately 40% of all pituitary adenomas. The most important clinical problems associated with prolactinomas are hypogonadism, infertility and hyposexuality. In patients with macroprolactinomas, mass effects, including visual field defects, headaches and neurological ...
COLAO, ANNAMARIA, SAVASTANO, SILVIA
openaire   +4 more sources

Home - About - Disclaimer - Privacy